Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Veterinary and Comparative Oncology|October 11, 2014
Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsiesK Autio, A Knuuttila, A Kipar, et al.
Gene Therapy|March 23, 2007
Luciferase imaging for evaluation of oncolytic adenovirus replication in vivoK Guse, J D Dias, G J Bauerschmitz, et al.
Gene Therapy|November 11, 2011
Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4J D Dias, O Hemminki, I Diaconu, et al.
Cancer Gene Therapy|December 25, 2010
Oncolytic adenovirus based on serotype 3O Hemminki, G Bauerschmitz, S Hemmi, et al.
Gene Therapy|August 30, 2008
Extended release of adenovirus from silica implants in vitro and in vivoL Kangasniemi, M Koskinen, M Jokinen, et al.
Gene Therapy|September 24, 2004
Noninvasive dual modality in vivo monitoring of the persistence and potency of a tumor targeted conditionally replicating adenovirusA Kanerva, K R Zinn, K-W Peng, et al.
Cancer Gene Therapy|September 4, 2023
Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokineD C A Quixabeira, E Jirovec, S Pakola, et al.
Cancer Gene Therapy|November 10, 2023
Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancerD C A Quixabeira, S Pakola, E Jirovec, et al.
Gene Therapy|March 19, 2010
Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumorsS Pesonen, P Nokisalmi, S Escutenaire, et al.
Pageof 3